InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Primocin® | Microbiota-derived tryptophan catabolites mediate the chemopreventive effects... | 2023 | Nat Microbiol. | Han J.X. et al. | DOI: 10.1038/s41564-023-01363-5 |
| Anti-mouse Dectin-1 (CLEC7A) antibody | The Alzheimer's disease risk factor INPP5D restricts neuroprotective microgli... | 2023 | Alzheimers Dement. | Samuels J.D. et al. | DOI: 10.1002/alz.13089 |
| Plasmocin® - Mycoplasma Elimination Reagent | The potential effects of in vitro digestion on the physicochemical and biolog... | 2023 | Environ Pollut. | Vela L. et al. | DOI: 10.1016/j.envpol.2023.121656 |
| Recombinant human IL-18 | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |
| IL-18 Reporter HEK 293 Cells | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |
| Normocin™ - Antimicrobial Reagent | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |
| Caspase-1 and Caspase-4 inhibitor | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |
| ODN 1826 VacciGrade™ | Immune responses to citrullinated and homocitrullinated peptides in healthy d... | 2023 | Immunology | Choudhury R.H. et al. | DOI: 10.1111/imm.13645 |
| MPLA Synthetic VacciGrade™ | Immune responses to citrullinated and homocitrullinated peptides in healthy d... | 2023 | Immunology | Choudhury R.H. et al. | DOI: 10.1111/imm.13645 |
| Puromycin | An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breas... | 2023 | Cancer Res. | Lu X.X. et al. | DOI: 10.1158/0008-5472.CAN-22-0536 |
| LPS-EB (LPS from E. coli O111:B4) | XIAP deletion sensitizes mice to TNF-induced and RIP1-mediated death. | 2023 | Cell Death Dis. | Witt A. et al. | DOI: 10.1038/s41419-023-05793-1 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Pushing the boundaries of structural heterogeneity with the lipid A of marine... | 2023 | Chembiochem. | Cirella R. et al. | DOI: 10.1002/cbic.202300183 |
| HEK-Blue™ Null2 Cells | Pushing the boundaries of structural heterogeneity with the lipid A of marine... | 2023 | Chembiochem. | Cirella R. et al. | DOI: 10.1002/cbic.202300183 |
| HEK-Blue™ Selection | Pushing the boundaries of structural heterogeneity with the lipid A of marine... | 2023 | Chembiochem. | Cirella R. et al. | DOI: 10.1002/cbic.202300183 |
| Pam3CSK4 | Pushing the boundaries of structural heterogeneity with the lipid A of marine... | 2023 | Chembiochem. | Cirella R. et al. | DOI: 10.1002/cbic.202300183 |
| CL264 | TLR7 activation in M-CSF-dependent monocyte-derived human macrophages potenti... | 2023 | J Innate Immun. | Simón-Fuentes M. et al. | DOI: 10.1159/000530249 |
| Blasticidin | Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppress... | 2023 | Neoplasia | Cui X. et al. | DOI: 10.1016/j.neo.2023.100900 |
| Puromycin | Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppress... | 2023 | Neoplasia | Cui X. et al. | DOI: 10.1016/j.neo.2023.100900 |
| OVA peptides | Synergistic effects of combined immunotherapy strategies in a model of multif... | 2023 | Cell Rep Med. | Ochoa M.C. et al. | DOI: 10.1016/j.xcrm.2023.101009 |
| Human TLR2 and TLR1 Reporter HEK293 Cells (NF-κB) | Engineered Curli Nanofilaments as a Self‐Adjuvanted Antigen Delivery Platform. | 2023 | Adv Healthc Mater. | Lamontagne F. et al. | DOI: 10.1002/adhm.202300224 |